Heart failure as a general pandemic in Asia

European Journal of Heart Failure

Volumn 17, Issue 9, 2015, Pages 884-892

  Shimokawa, Hiroaki ^a   Miura, Masanobu ^a   Nochioka, Kotaro ^a   Sakata, Yasuhiko ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ageing; Asia; Heart failure; Prevention

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OLMESARTAN; VASODILATOR AGENT;

ACUTE HEART FAILURE; AGING; ASIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE REGISTRY; HEALTH CARE MANAGEMENT; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; ISCHEMIC HEART FAILURE; MULTICENTER STUDY (TOPIC); PANDEMIC; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TREATMENT OUTCOME; MORBIDITY; REGISTER; SURVIVAL RATE; TRENDS;

ASIA; HEART FAILURE; HUMANS; MORBIDITY; REGISTRIES; SURVIVAL RATE;

EID: 84941786961     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.319     Document Type: Review

References (70)

1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CS, Sato N, Shah AN, Gheorghiade M,. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123-1133.
2. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D,; Framingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106: 3068-3072.
3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB,; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292.
4. Guo Y, Lip GY, Banerjee A,. Heart failure in East Asia. Curr Cardiol Rev 2013; 9: 112-122.
5. Pillai HS, Ganapathi S,. Heart failure in South Asia. Curr Cardiol Rev 2013; 9: 102-111.
6. Sakata Y, Shimokawa H,. Epidemiology of heart failure in Asia. Circ J 2013; 77: 2209-2217.
7. Huffman MD, Prabhakaran D,. Heart failure: epidemiology and prevention in India. Natl Med J India 2010; 23: 283-288.
8. Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, Suzuki K, Tanabe N, Kodama M, Aizawa Y,. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 2008; 72: 489-491.
9. Ng TP, Niti M,. Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998. Heart 2003; 89: 865-870.
10. Chong AY, Rajaratnam R, Hussein NR, Lip GY,. Heart failure in a multiethnic population in Kuala Lumpur, Malaysia. Eur J Heart Fail 2003; 5: 569-574.
11. Tseng CH,. Clinical features of heart failure hospitalization in younger and elderly patients in Taiwan. Eur J Clin Invest 2011; 41: 597-604.
12. National Center for Cardiovascular Diseases, China. Report on Cardiovascular Diseases in China (2011)., Hu Shengshou, Kong Lingzhi, eds. Beijing, China: Encyclopedia of China Publishing House,; 2014.
13. United Nations, Department of Economic and Social Affairs, Population Division. File POP/7-1: Total population (both sexes combined) by five-year age group, major area, region and country, 1950-2100 (thousands). World population prospects: the 2012 revision. http://esa.un.org/unpd/wpp/Excel-Data/population.htm (31 May 2015)
14. Seferovic PM, Stoerk S, Filippatos G, Mareev V, Kavoliuniene A, Ristic AD, Ponikowski P, McMurray J, Maggioni A, Ruschitzka F, van Veldhuisen DJ, Coats A, Piepoli M, McDonagh T, Riley J, Hoes A, Pieske B, Dobric M, Papp Z, Mebazaa A, Parissis J, Ben Gal T, Vinereanu D, Brito D, Altenberger J, Gatzov P, Milinkovic I, Hradec J, Trochu JN, Amir O, Moura B, Lainscak M, Comin J, Wikström G, Anker S,; Committee of National Heart Failure Societies or Working Groups of the Heart Failure Association of the European Society of Cardiology. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups. Eur J Heart Fail 2013; 15: 947-59.
15. http://www.stat.go.jp/data/topics/pdf/topics72.pdf (5 June 2015)
16. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H, on behalf of the CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan-first report from the CHART-2 Study. Circ J 2011; 75: 823-833.
17. Miura M, Shiba N, Nochioka K, Takada T, Takahashi J, Kohno H, Shimokawa H,; CHART-2 Investigators. Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study. Eur J Heart Fail 2012; 14: 367-376.
18. Takada T, Sakata Y, Miyata S, Takahashi J, Nochioka K, Miura M, Tadaki S, Shimokawa H,. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study. Eur J Heart Fail 2014; 16: 309-316.
19. Sakata Y, Miyata S, Nochioka K, Miura M, Takada T, Tadaki S, Takahashi J, Shimokawa H,. Gender differences in clinical characteristics, treatment and long-term outcome in patients with Stage C/D heart failure in Japan. Circ J 2014; 78: 428-435.
20. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H,; JCARE-CARD Investigators. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction: Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1893-1900.
21. Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H,; JCARE-CARD Investigators. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: A report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 2012; 76: 1920-1927.
22. Kajimoto K, Sato N, Keida T, Mizuno M, Sakata Y, Asai K, Takano T,; investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Association between length of stay, frequency of in-hospital death, and causes of death in Japanese patients with acute heart failure syndromes. Int J Cardiol 2013; 168: 554-556.
23. Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, Asai K, Murai K, Muanakata R, Aokage T, Sakata Y, Mizuno K, Takano T,; ATTEND Investigators. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 2013; 77: 944-951.
24. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP,; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-216.
25. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L,; EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006; 27: 2725-2736.
26. Atherton JJ, Hayward CS, Wan Ahmad WA, Kwok B, Jorge J, Hernandez AF, Liang L, Kociol RD, Krum H,; ADHERE International-Asia Pacific Scientific Advisory Committee. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). J Card Fail 2012; 18: 82-88
27. Khan M, Jehangir W, Daood MS, Khan A, Mallick NH,. Frequency of anaemia and renal insufficiency in patients with heart failure. J Ayub Med Coll Abbottabad 2010; 22: 87-89.
28. http://hdr.undp.org/en/statistics/ (5 June 2015)
29. Nochioka K, Shiba N, Kohno H, Miura M, Shimokawa H,. Both high and low body mass indexes are prognostic risks in Japanese patients with chronic heart failure: implications from the CHART Study. J Card Fail 2010; 16: 880-887.
30. Youn YJ, Yoo BS, Lee JW, Kim JY, Han SW, Jeon ES, Cho MC, Kim JJ, Kang SM, Chae SC, Oh BH, Choi DJ, Lee MM, Ryu KH,; KorHF Registry. Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry. Circ J 2012; 76: 1151-1158.
31. Yin Q, Zhao Y, Li J, Xue Q, Wu X, Gao L, He P, Zhu M, Wang S,. The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing. Clin Cardiol 2011; 34: 442-446.
32. Yu SB, Cui HY, Qin M, Kong B, Liu T, Zhao QY, Huang H, Yang B, Huang CX,. Characteristics of in-hospital patients with chronic heart failure in Hubei province from 2000 to 2010. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 549-552 (in Chinese).
33. Grover A, Vijayvergiya R, Thingam ST,. Burden of rheumatic and congenital heart disease in India: lowest estimate based on the 2001census. Indian Heart J 2002; 54: 104-107.
34. Joshi PP, Mohanan CJ, Sengupta SP, Salkar RG,. Factors precipitating congestive heart failure-role of patient non-compliance. J Assoc Physicians India 1999; 47: 294-295.
35. Jindal SK,. Emergence of chronic obstructive pulmonary disease as an epidemic in India. Indian J Med Res 2006; 124: 619-630.
36. Parekh DR,. A review of heart failure in adults with congenital heart disease. Methodist Debakey Cardiovasc J 2011; 7: 26-32.
37. Lee SE, Cho HJ, Lee HY, Yang HM, Choi JO, Jeon ES, Kim MS, Kim JJ, Hwang KK, Chae SC, Seo SM, Baek SH, Kang SM, Oh IY, Choi DJ, Yoo BS, Ahn Y, Park HY, Cho MC, Oh BH,. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail 2014; 16: 700-8.
38. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, Hasebe Y, Segawa M, Shimokawa H,; CHART-2 Investigators. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure. Circ J 2015; 79: 381-390.
39. JCS Joint Working Group. Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). Circ J 2013; 77: 249-274.
40. Yusuf S, Reddy S, Ounpuu S, Anand S,. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753.
41. Omran AR,. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971; 49: 509-538.
42. Zuckerman MK, Harper KN, Barrett R, Armelagos GJ,. The evolution of disease: anthropological perspectives on epidemiologic transitions. Glob Health Action 2014; 7: 23303.
43. Reddy KS, Yusuf S,. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601.
44. Hao K, Yasuda S, Takii T, Ito Y, Takahashi J, Ito K, Nakayama M, Shiba N, Fukumoto Y, Shimokawa H,; MIYAGI-AMI Study Investigators. Urbanization, life style changes and the incidence/in-hospital mortality of acute myocardial infarction in Japan: report from the MIYAGI-AMI Registry Study. Circ J 2012; 76: 1136-1144.
45. Pei ZY, Zhao YS, Li JY, Xue Q, Gao L, Wang SW,. Fifteen-year evolving trends of etiology and prognosis in hospitalized patients with heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 434-439 (in Chinese).
46. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW,; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180-189.
47. Mohanan PP, Mathew R, Harikrishnan S, Krishnan MN, Zachariah G, Joseph J, Eapen K, Abraham M, Menon J, Thomas M, Jacob S, Huffman MD, Prabhakaran D,; Kerala ACS Registry Investigators. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J 2013; 34: 121-129.
48. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, Joshi P, Kerkar P, Thanikachalam S, Haridas KK, Jaison TM, Naik S, Maity AK, Yusuf S,; CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008; 371: 1435-1442.
49. Sen K, Bonita R,. Global health status: two steps forward, one step back. Lancet 2000; 356: 577-582.
50. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS,. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008; 118: 2057-2062.
51. Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA,. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol 2009; 53: 13-20.
52. Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, Shirato K,; CHART Investigators. Analysis of chronic heart failure registry in the Tohoku district: third year follow-up. Circ J 2004; 68: 427-434.
53. Ushigome R, Sakata Y, Nochioka K, Miyata S, Miura M, Tadaki S, Yamauchi T, Sato K, Onose T, Tsuji K, Abe R, Takahashi J, Shimokawa H,; on behalf of CHART-2 Investigators. Improved long-term prognosis of patients with dilated cardiomyopathy with implementation of evidenced-based medications-a report from the CHART Studies Circ J 2015; 79: 1332-1324.
54. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC,; Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 2012; 126: 65-75.
55. Nochioka K, Sakata Y, Miyata S, Miura M, Takada T, Tadaki S, Ushigome R, Yamauchi T, Takahashi J, Shimokawa H,; CHART-2 Investigators. Prognostic impact of statin use in patients with heart failure and preserved ejection fraction. Circ J 2015; 79: 574-582.
56. Komajda M, Lam CS,. Heart failure with preserved ejection fraction: a clinical dilemma. Eur Heart J 2014; 35: 1022-1032.
57. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A,; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359: 2456-2467.
58. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM,; TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014; 370: 1383-1392.
59. Yamamoto K, Origasa H, Hori M,; J-DHF Investigators. Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). Eur J Heart Fail 2013; 15: 110-118.
60. Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O'Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B,. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation 2015; 131: 34-42.
61. Kristensen SL, Køber L, Jhund PS, Solomon SD, Kjekshus J, McKelvie RS, Zile MR, Granger CB, Wikstrand J, Komajda M, Carson PE, Pfeffer MA, Swedberg K, Wedel H, Yusuf S, McMurray JJ,. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. Circulation 2015; 131: 43-53.
62. Sakata Y, Shiba N, Takahashi J, Miyata S, Nochioka K, Miura M, Takada T, Saga C, Shinozaki T, Sugi M, Nakagawa M, Sekiguchi N, Komaru T, Kato A, Fukuchi M, Nozaki E, Hiramoto T, Inoue K, Goto T, Ohe M, Tamaki K, Ibayashi S, Ishide N, Maruyama Y, Tsuji I, Shimokawa H,; on Behalf of the SUPPORT Trial Investigators. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial. Eur Heart J 2015; 36: 915-923.
63. Ho KK, Pinsky JL, Kannel WB, Levy D,. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
64. United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: the 2012 revision. http://esa.un.org/unpd/wpp/Excel-Data/population.htm (5 June 2015)
65. Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE,. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 2014; 63: 747-762.
66. Persinger R, Janssen-Heininger Y, Wing SS, Matthews DE, Lewinter MM, Toth MJ,. Effect of heart failure on the regulation of skeletal muscle protein synthesis, breakdown, and apoptosis. Am J Physiol Endocrinol Metab 2003; 284: E1001-E1008.
67. Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, Rodríguez F, Fernández G,. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 2005; 20: 38-45.
68. Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, Fukumoto Y, Shiba N, Shimokawa H,; CHART-2 Investigators. Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: a report from the CHART-2 Study. Circ J 2013; 77: 2318-2326.
69. Miura M, Sakata Y, Nochioka K, Takada T, Tadaki S, Ushigome R, Yamauchi T, Takahashi J, Miyata S, Shiba N, Shimokawa H,. Prevalence, predictors and prognosis of patients with heart failure requiring nursing care. Circ J 2014; 78: 2276-2283.
70. Miura Y, Fukumoto Y, Miura T, Shimada K, Asakura M, Kaokami T, Ando S, Miyata, S, Sakata Y, Daida H, Matsuzaki M, Yasuda S, Kitakaze M, Shimokawa H,. Impact of physical activity on cardiovascular events in patients with chronic heart failure-a multi-center prospective cohort study. Circ J 2013; 77: 2963-2972.